These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33647745)

  • 1. Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides.
    Abram M; Rapacz A; Latacz G; Szulczyk B; Kalinowska-Tłuścik J; Otto-Ślusarczyk D; Struga M; Kamiński RM; Kamiński K
    Bioorg Chem; 2021 Apr; 109():104751. PubMed ID: 33647745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
    Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
    Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies.
    Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Kamiński RM; Kamiński K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
    Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
    Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.
    Kamiński K; Rapacz A; Filipek B; Obniska J
    Bioorg Med Chem; 2016 Jul; 24(13):2938-2946. PubMed ID: 27211245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
    Kamiński K; Zagaja M; Łuszczki JJ; Rapacz A; Andres-Mach M; Latacz G; Kieć-Kononowicz K
    J Med Chem; 2015 Jul; 58(13):5274-86. PubMed ID: 26052884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.
    Socała K; Mogilski S; Pieróg M; Nieoczym D; Abram M; Szulczyk B; Lubelska A; Latacz G; Doboszewska U; Wlaź P; Kamiński K
    ACS Chem Neurosci; 2019 Jan; 10(1):636-648. PubMed ID: 30247871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents.
    Abram M; Rapacz A; Mogilski S; Latacz G; Lubelska A; Kamiński RM; Kamiński K
    ACS Chem Neurosci; 2020 Jul; 11(13):1996-2008. PubMed ID: 32479058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides.
    Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Szulczyk B; Szafarz M; Socała K; Nieoczym D; Wyska E; Wlaź P; Kamiński RM; Kamiński K
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
    Rapacz A; Kamiński K; Obniska J; Koczurkiewicz P; Pękala E; Filipek B
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):567-579. PubMed ID: 28188357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Anticonvulsant Properties of New 3,3-Diphenyl-2,5-dioxo-pyrrolidin-1-yl-acetamides and 3,3-Diphenyl-propionamides.
    Obniska J; Rapacz A; Rybka S; Góra M; Żmudzki P; Kamiński K
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug.
    Kamiński K; Socała K; Zagaja M; Andres-Mach M; Abram M; Jakubiec M; Pieróg M; Nieoczym D; Rapacz A; Gawel K; Esguerra CV; Latacz G; Lubelska A; Szulczyk B; Szewczyk A; Łuszczki JJ; Wlaź P
    Neurotherapeutics; 2020 Jan; 17(1):309-328. PubMed ID: 31486023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.
    Obniska J; Rapacz A; Rybka S; Powroźnik B; Pękala E; Filipek B; Żmudzki P; Kamiński K
    Eur J Med Chem; 2015 Sep; 102():14-25. PubMed ID: 26241874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2,6-dicarbethoxy-3,5-diaryltetrahydro-1,4-thiazine-1,1-dioxide derivatives as potent anticonvulsant agents.
    Edayadulla N; Ramesh P
    Eur J Med Chem; 2015 Dec; 106():44-9. PubMed ID: 26519928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
    Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
    Ugale VG; Bari SB
    Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant Activity of Enantiomeric N-trans-Cinnamoyl Derivatives of 2-Aminopropan-1-ols and 2-Aminobutan-1-ols.
    Gunia-Krzyżak A; Żesławska E; Nitek W; Popiół J; Marona H
    Chirality; 2016 Jun; 28(6):482-8. PubMed ID: 27121961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, and anticonvulsant activity of new amides derived from 3-methyl- or 3-ethyl-3-methyl-2,5-dioxo-pyrrolidin-1-yl-acetic acids.
    Obniska J; Rapacz A; Rybka S; Góra M; Kamiński K; Sałat K; Żmudzki P
    Bioorg Med Chem; 2016 Apr; 24(8):1598-607. PubMed ID: 26970661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants.
    Jakubiec M; Abram M; Zagaja M; Andres-Mach M; Szewczyk A; Latacz G; Szulczyk B; Socała K; Nieoczym D; Wlaź P; Metcalf CS; Wilcox K; Kamiński RM; Kamiński K
    Cells; 2022 Jun; 11(12):. PubMed ID: 35740990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.